PRGO — Perrigo Company PLC
NYSE · Pharmaceuticals · Pharmaceuticals
- Latest Close
- $11.82
- 30-Day Move
- -12.0%
- Market Cap
- $1.3B
- Shares Outstanding
- 137,650,000
- P/B Ratio
- 0.65
- ROE
- -48.6%
Analyst consensus: Buy · 10 analysts
Perrigo Company PLC
A read-only Alphactor snapshot for Perrigo Company PLC. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of 2026-04-22
Topline snapshot
Latest Close
$11.82
30-Day Move
-12.0%
Market Cap
$1.3B
Shares Outstanding
137,650,000
P/B Ratio
0.65
ROE
-48.6%
$11.82
-12.0%last 90 delayed daily bars
90D High
$15.38
90D Low
$9.22
Avg Volume
3,394,322
Gross margin is running at 35.1%, which gives a quick read on operating quality before you open the full model.
Net margin is -33.5%, useful for comparing PRGO against peers in Pharmaceuticals.
PRGO is down 12.0% over the last 30 trading days shown on this page.
Latest operating income is $313M, which helps anchor the headline ratios with an actual earnings figure.
Composite Fair Value
$131.91
Rule of 40
0.7%
Dark Pool Short %
51.8%
Latest Close
$11.82
30-Day Move
-12.0%
Market Cap
$1.3B
Shares Outstanding
137,650,000
P/B Ratio
0.65
ROE
-48.6%
ROA
-16.7%
Gross Margin
35.1%
Operating Margin
-26.4%
Net Margin
-33.5%
Debt / Equity
1.24
Current Ratio
2.76
Dividend Yield
12.0%
Latest Revenue
$4.3B
Revenue
$4.3B
Gross Profit
$1.5B
Operating Income
$313M
Net Income
$-1.4B
Gross Margin
3514.0%
Net Margin
-3351.0%
Current Ratio
2.76
Debt / Equity
1.24
Fair Value
$131.91
Upside / Downside
+1016.0%
Signal
Undervalued
Implied Growth
14.3%
EV/Rev
$131.91
Growth Assumption
-1.5%
Discount Rate
10.1%
Terminal Growth
2.0%
Base FCF
$145M
Valuation spread
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Moderate growth priced in
Altman Z
0.41
Distress
Piotroski
5
Moderate (4-6)
Cash Conversion
-0.17x
Rule of 40
0.7%
Concerning
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $4.5B | $121M | $-141M | $211M |
| 2023-12-31 | $4.7B | $284M | $-13M | $304M |
| 2024-12-31 | $4.4B | $312M | $-172M | $245M |
| 2025-12-31 | $4.3B | $313M | $-1.4B | $145M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
Buy Value
$562,500.03
Sell Value
$0
Buys
10
Sells
0
Buy Value
$562,500.03
Sell Value
$0
Buy/Sell Ratio
10.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-02 | Lockwood-Taylor Patrick | M | 17,834 | $0.00 |
| 2026-04-02 | Lockwood-Taylor Patrick | F | 9,123 | $10.85 |
| 2026-04-02 | Lockwood-Taylor Patrick | M | 17,834 | $10.85 |
| 2026-04-02 | Willis Robert | M | 2,070 | $0.00 |
| 2026-04-02 | Willis Robert | F | 1,081 | $10.85 |
| 2026-04-02 | Willis Robert | M | 2,070 | $10.85 |
| 2026-04-02 | Bezerra Eduardo Guarita | M | 6,369 | $0.00 |
| 2026-04-02 | Bezerra Eduardo Guarita | F | 1,551 | $10.85 |
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| T. Rowe Price Mid-Cap Value Fund, Inc. | 9,565,343 | 0.07% | 2025-12-31 |
| iShares Trust-iShares Core S&P Small-Cap ETF | 8,358,785 | 0.06% | 2026-02-28 |
| UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd. | 6,401,436 | 0.05% | 2025-12-31 |
| -Price (T.Rowe) Mid-Cap Value Equity Trust | 5,900,502 | 0.04% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4,343,219 | 0.03% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 3,116,262 | 0.02% | 2025-12-31 |
| Invesco Exch-Trd Fd. TRT-Invesco High Yield Eqy. Dividend Achievers ET | 2,569,199 | 0.02% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 2,013,646 | 0.01% | 2025-12-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
BlackRock
Filed 2024-05-10
$420M
--
Vanguard Group
Filed 2025-05-09
$392M
-6.1%
Geode Capital Management
Filed 2025-08-08
$66M
-2.7%
Invesco
Filed 2026-02-19
$63M
+134.2%
Citadel Advisors
Filed 2025-05-15
$52M
--
3.8
Consensus
Buy—
—
—
10
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.